Investors
Please register your interest using the form. We expect to have an investor portal opening soon to provide you with real time updates and Company communication.
Corporate Profile
Releaf Dispensary Ltd (“Releaf”) is a sophisticated health and technology entrant to the UK’s growing medicinal cannabis sector. The Company transforms how patients acquire, use and experience medicinal cannabis, through an exciting, all-in-one monthly subscription that truly delivers safety, convenience, and choice for patients.
Releaf has changed the game and completely rewritten the flow, giving patients a perfectly balanced brand between clinical and lifestyle, offering patients the first all-in-one cannabis solution. Releaf has spent a great deal of time working with user experience professionals, award-winning designers, and developers to build an industry-leading website and a custom back-end platform to manage the entire customer life cycle.
We believe that patients should have access to the treatment they need, without the stigma or hefty price tag. Our service is tailored to each individual patient and our experts provide top-quality care, with ongoing support and adjustments as needed. We believe that medicinal cannabis is an essential and effective treatment for a wide range of conditions, including chronic pain, insomnia and neurological diseases. Our goal is to break down the stigma and mystery attached to medical cannabis, to provide safe and affordable healthcare to patients all over the UK.
We prescribe, dispense monthly and give the users everything they need to start their cannabis treatment plan. In addition, patients will be given a luxury welcome pack containing a premium grinder, storage container, vaporiser and the all-important Releaf medicinal cannabis card. Releaf carefully selected each item that contains our branding to ensure it is of superior quality, making every interaction with our brand have a quality feel.
Investor Information
Releaf is currently raising funds from certified High-Net-Worth Investors and Sophisticated Investors only. Should you wish to contact the Company for information about the process, please email investors@releaf.co.uk. The Company is not in a position to give financial advice and you should speak to your financial advisor before making any decision.
Receiving Agent and Releaf:
For the interest of transparency, the Company is using a Receiving Agent (Robert Lewis Accountant). Only funds transferred directly to the receiving agent's account or our own account listed on the application form, or by cheque will be considered received by Releaf. If you are in any doubt as to whether your funds have been received, please contact Investors@releaf.co.uk. The Company is not responsible for funds transferred to any other party other than the ones listed below.
Escrow: Robert Lewis Redbond Ruggieri & Co Limited Direct:
Releaf Dispensary Ltd
Bank details available on request
Investor Communication and Portal:
All official investor communication from Releaf will be posted on this page and emailed from the Investors@releaf.co.uk account. We may from time to time post investor updates via third party sources such as the LSE, however all communications can be verified by what's on this page. Releaf takes no responsibility for unauthorised communications through external parties and websites and investors should place no reliance on them.
Releaf will be launching an Investor Portal with individual logins to receive up-to-date company information as we progress through our development program. Details will be announced through the investor communication email including how to register and sign up. If you are a current investor, please fill out the attached form to register for the upcoming portal. We will match the details to the information we have on file and issue you with a login password to our Investor Portal when it is ready.
Please contact investors@releaf.co.uk for further information regarding the Company. Should you wish to discuss anything else, see relevant contact details on our contact page.
Register your interest
High Net Worth Individual: An individual with an annual income to the value of £100,000 or more and/ or net assets to the value of £250,000 or more (cannot include your home residence), throughout the financial year immediately preceding today’s date
Sophisticated Investor: You have made more than one investment in an unlisted company in the two years prior to the date below and/ or currently, or have been in the two years prior to the date below, a director of a company with an annual turnover of at least £1 million.
Disclaimer: This Investment opportunity is not open retail investors you must qualify as either a high net worth individual or a sophisticated investor.
High Net Worth Individual: An individual with an annual income to the value of £100,000 or more and/ or net assets to the value of £250,000 or more (cannot include your home residence), throughout the financial year immediately preceding today’s date
Sophisticated Investor: You have made more than one investment in an unlisted company in the two years prior to the date below and/ or currently, or have been in the two years prior to the date below, a director of a company with an annual turnover of at least £1 million.
Releaf Dispensary Ltd ‘Releaf’ are an early stage unquoted (unlisted) limited limited company. Releaf are NOT covered by the Financial Services Compensation Scheme (FSCS) or the Financial Ombudsman Service (FOS).
Releaf and its directors, employees, officers, affiliates, consultants, advisors or agents do not provide financial, investment, tax, legal, accounting, or any other kind of advice or advise on the suitability and appropriateness of Bauer Bridge.
The information provided on our site is NOT intended to provide financial, investment, tax, legal, accounting or any other kind of advice.
Neither Releaf Dispensary or any of its directors, officers, affiliates, employees, advisers, consultants and agents makes investment recommendations to you. No communication from Releaf or any of its directors, officers, affiliates, employees, advisers, consultants and agents, through our site or any other medium, should be construed as a recommendation regarding any security.
Further, nothing on our site shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful.
Releaf and any of its directors, officers, affiliates, employees, advisers, consultants and agents makes no guarantee of any specific results from the use of our site or any other medium.
Any investment decision should be made solely on the basis of the Terms of the Information Memorandum (subject to and all disclaimers and limitations set out therein) and subject to the Terms and Conditions set out on therein and Articles of Association of Releaf.
Users should be aware that they use our site and its content at their own risk. If you are in any doubt about the action you should take or the contents of this Information Memorandum, you should contact your stockbroker, solicitor, accountant, bank manager or other professional adviser authorised under the Financial Services and Markets Act 2000 (as amended).
Please confirm you have read and understood this statement by clicking the button.